Related references
Note: Only part of the references are listed.Sustained reductions of invasive infectious disease following general infant Haemophilus influenzae type b and pneumococcal vaccination in a Swedish Arctic region
Urban Johansson Kostenniemi et al.
ACTA PAEDIATRICA (2019)
The changing epidemiology of community-acquired pneumonia: nationwide register-based study in Sweden
P. Naucler et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Limited indirect effects of an infant pneumococcal vaccination program in an aging population
Mark van der Linden et al.
PLOS ONE (2019)
Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland
Sigridur J. Quirk et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination
Germaine Hanquet et al.
THORAX (2019)
Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15
Heather J. Adam et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis
Evelyn Balsells et al.
JOURNAL OF INFECTION (2018)
Aerobic bacteria associated with chronic suppurative otitis media in Angola
Fabian Udden et al.
INFECTIOUS DISEASES OF POVERTY (2018)
Streptococcus pneumoniae serotype 19A: worldwide epidemiology
Raul Isturiz et al.
EXPERT REVIEW OF VACCINES (2017)
Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination A National Observational Study
Marie Gisselsson-Solen
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: The emergence of multidrug resistant serotype 6C
Felipe P. G. Neves et al.
VACCINE (2017)
Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations (Publication with Expression of Concern. See vol. 68, pg. 534, 2019)
Pontus Naucler et al.
CLINICAL INFECTIOUS DISEASES (2017)
Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county
Nils Littorin et al.
BMC INFECTIOUS DISEASES (2016)
Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
Ilias Galanis et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden
Ann Lindstrand et al.
VACCINE (2016)
Noninvasive Streptococcus pneumoniae Serotypes Recovered from Hospitalized Adult Patients in the United States in 2009 to 2012
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
Mark van der Linden et al.
BMC INFECTIOUS DISEASES (2015)
Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States
Sandra S. Richter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children
Mark van der Linden et al.
BMC INFECTIOUS DISEASES (2013)
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
Ron Dagan et al.
CLINICAL INFECTIOUS DISEASES (2013)
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
Anneke Steens et al.
VACCINE (2013)
Share Paper
